Spots Global Cancer Trial Database for folfox6
Every month we try and update this database with for folfox6 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Efficacy of FOLFOX Alone, FOLFOX Plus Bevacizumab and FOLFOX Plus Panitumumab in Patients With Resectable Liver Metastases | NCT01508000 | Colorectal Canc... Liver Metastase... KRAS Wild Type ... | FOLFOX6 Bevacizumab Panitumumab Surgery | 18 Years - 75 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
BKM120 + mFOLFOX6 in Advanced Solid Tumors With Expansion Cohort Pancreatic Cancer | NCT01571024 | Advanced Solid ... Metastatic Colo... Metastatic Panc... | BKM120 mFOLFOX6 | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
Chemoradiation or Brachytherapy for Rectal Cancer | NCT02017704 | Rectal Cancer | Endo-HDR (if ra... capecitabine an... IMRT (intensity... FOLFOX6 Surgery | 18 Years - 100 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
A Phase II Study to Determine the Safety and Efficacy of Second-line Treatment With Metformin and Chemotherapy (FOLFOX6 or FOFIRI) in the Second Line Threatment of Advanced Colorectal Cancer | NCT01926769 | Previously Trea... | Metformin | 18 Years - | Gachon University Gil Medical Center | |
Study on FOLFOX6 as First-line Therapy to Treat Recurrent or Metastatic Esophageal Cancer | NCT01605305 | Esophageal Squa... | FOLFOX6 | 18 Years - 75 Years | Fudan University | |
Chemoradiation or Brachytherapy for Rectal Cancer | NCT02017704 | Rectal Cancer | Endo-HDR (if ra... capecitabine an... IMRT (intensity... FOLFOX6 Surgery | 18 Years - 100 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
Phase II Study of Chemo-Radiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer | NCT02243358 | Pancreas Neopla... | Folfox6 Gemcitabine Radiation Thera... Pancreaticoduod... | 18 Years - 99 Years | Henry Ford Health System | |
5-FU, Aflibercept, and Radiation (RT) for Preoperative and Postoperative Patients With Stage II/III Rectal Cancer | NCT01749956 | Rectal Cancer | Radiation Aflibercept Surgery FOLFOX6 | 18 Years - | SCRI Development Innovations, LLC | |
A Phase II Study to Determine the Safety and Efficacy of Second-line Treatment With Metformin and Chemotherapy (FOLFOX6 or FOFIRI) in the Second Line Threatment of Advanced Colorectal Cancer | NCT01926769 | Previously Trea... | Metformin | 18 Years - | Gachon University Gil Medical Center | |
Chemoradiation or Brachytherapy for Rectal Cancer | NCT02017704 | Rectal Cancer | Endo-HDR (if ra... capecitabine an... IMRT (intensity... FOLFOX6 Surgery | 18 Years - 100 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
Study Comparing Optimized 5-FU Dosing and Standard Dosing in Metastatic Colorectal Cancer Patients Treated With mFOLFOX6 | NCT01468623 | Colorectal Canc... | Pharmacokinetic... Standard of car... | 18 Years - | Myriad Genetic Laboratories, Inc. | |
Chemoradiation or Brachytherapy for Rectal Cancer | NCT02017704 | Rectal Cancer | Endo-HDR (if ra... capecitabine an... IMRT (intensity... FOLFOX6 Surgery | 18 Years - 100 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
A Phase II Study to Determine the Safety and Efficacy of Second-line Treatment With Metformin and Chemotherapy (FOLFOX6 or FOFIRI) in the Second Line Threatment of Advanced Colorectal Cancer | NCT01926769 | Previously Trea... | Metformin | 18 Years - | Gachon University Gil Medical Center | |
BKM120 + mFOLFOX6 in Advanced Solid Tumors With Expansion Cohort Pancreatic Cancer | NCT01571024 | Advanced Solid ... Metastatic Colo... Metastatic Panc... | BKM120 mFOLFOX6 | 18 Years - | UNC Lineberger Comprehensive Cancer Center |